We need your support to keep TheyWorkForYou running and make sure people across the UK can continue to hold their elected representatives to account.

Donate to our crowdfunder

Human Papillomavirus: Vaccination

Department of Health and Social Care written question – answered on 27th June 2018.

Alert me about debates like this

Photo of Baroness Altmann Baroness Altmann Conservative

To ask Her Majesty's Government what is the Joint Committee on Vaccination and Immunisation's latest assessment of the proportion of cancers which are caused by vaccine-preventable types of human papillomavirus.

Photo of Lord O'Shaughnessy Lord O'Shaughnessy The Parliamentary Under-Secretary for Health and Social Care

The Joint Committee on Vaccination and Immunisation (JCVI) published an interim statement on extending the human papillomavirus (HPV) vaccination to adolescent boys in July 2017. The interim statement and the following table set out the proportion of cancers attributable to HPV infection by disease, as modelled by Public Health England (PHE). A copy of the JCVI Interim Statement on Extending HPV Vaccination to Adolescent Boys is attached.

Cancer site (females)

High-risk HPV type (attribution fraction)


HPV16/18/31/33/45/52/58/other (35/39/51/56/59/68) (95.1%)


HPV16/18/33 (12.7%)


HPV16 (53.7%)


HPV16/18/33 (77.0%)


HPV16 (24.7%)

Oral cavity

HPV16/18 (1.1%)


HPV16/18 (1.9%)

Cancer site (males)

High-risk HPV type (attribution fraction)


HPV16/18/33 (77.0%)


HPV16/18 (28.6%)


HPV16 (12.8%)

Oral cavity

HPV16/18 (1.4%)


HPV16/18 (0.6%)


Attributable fraction for high risk HPV types associated with cancer as modelled by PHE and based on International Agency for Research on Cancer reviews.

The JCVI most recently considered HPV vaccination on 6 June 2018, and the minutes of that meeting will be published on or before 18 July 2018.

Extending_HPV_Vaccination (PDF Document, 219.47 KB)

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.